Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene

Genes and Development

Volumn 12, Issue 19, 1998, Pages 3084-3095

  Hua, Xianxin ^a   Liu, Xuedong ^a   Ansari, Dominic O ^a   Lodish, Harvey F ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

E box; PAI 1; Smads; TFE3; TGF

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL GROWTH; DNA LIBRARY; DNA SEQUENCE; MOLECULAR CLONING; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RETROVIRUS; VIRUS MUTATION; WOUND HEALING;

UNIDENTIFIED RETROVIRUS;

EID: 0032191407     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.19.3084     Document Type: Article

References (44)

1. 467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272: 27678-27685.
2. Attisano, L. and J. Wrana. 1998. Mads and Smads in TGFβ signaling. Curr. Opin. Cell Biol. 10: 188-194.
3. Attisano, L., J.L. Wrana, F. Lopez-Casillas, and J. Massagué. 1994. TGF-β receptors and actions. Biochimica et Biophysica Acta 1222: 71-80.
4. Baker, B.W., D. Boettiger, E. Spooncer, and J.D. Norton. 1992. Efficient retroviral-mediated gene transfer into human B lymphoblastoid cells expressing mouse ecotropic viral receptor. Nucleic Acids Res. 20: 5234.
5. Beckmann, H., L.-K. Su, and T. Kadesch. 1990. TFE3: A helix-loop-helix protein that activates transcription through the immunoglobulin enhancer μE3 motif. Genes & Dev. 4: 167-179.
6. Chen, X., M.J. Rubock, and M. Whitman. 1996. A transcriptional partner for MAD proteins in TGF-β signalling. Nature 383: 691-696.
7. Chen, X., E. Weisberg, F. Fridmacher, M. Watanabe, G. Naco, and M. Whitman. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-89.
8. Chen, Y., J.-J. Lebrun, and W. Vale. 1996. Regulation of transforming growth factor β- and activin-induced transcription by mammalian Mad Proteins. Proc. Natl. Acad. Sci. 93: 12992-12997.
9. Datto, M.B., Y. Yu, and X.-F. Wang. 1995. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:28623-28628.
10. Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. Gambier. 1998. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type I gene. EMBO J. 17: 3091-3100.
11. Franzen, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C. Heldin, and K. Miyazono. 1993. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75: 681-692.
12. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
13. Heldin, C.-H., K. Miyazono, and P. ten Dijke. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
14. Hocevar, B. and P. Howe. 1996. Isolation and characterization of mutant cell lines defective in transforming growth factor β signalling. Proc. Natl. Acad. Sci. 93: 7655-7600.
15. Hua, X., A. Nohturfft, J.L. Goldstein, and M.S. Brown. 1996. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell 87: 415-426.
16. Keeton, M.R., S.A. Curriden, A.-J.V. Zonneveld, and D.J. Loskutoff. 1991. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforning growth factor-β. J. Biol. Chem. 266: 23048-23052.
17. Kim, I., K. Johnson, H.J. Chen, S. Carroll, and A. Laughon. 1997. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388: 304-308.
18. Kitamura, T., M. Onishi, S. Kinoshita, A. Shibuya, A. Miyanma, and G.P. Nolan. 1995. Efficient screening of retroviral cDNA expression libraries. Proc. Natl. Acad. Sci. 92: 9146-9150.
19. Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massague. 1996. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383: 832-836.
20. INK4B through an Sp1 consensus site. J. Biol. Chem. 270: 26750-26753.
21. Lin, H.Y. and H.F. Lodish. 1993. Receptors for the TGF-β superfamily: Multiple polypeptides and serine/threonine kinases. Trends Cell Biol. 3: 14-19.
22. Liu, F., C. Pouponnot, and J. Massague. 1997. Dual role of the Smad4/DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes & Dev. 11: 3157-3167.
23. Liu, X., Y. Sun, S.N. Constantinescu, E. Karam, R.A. Weinberg, and H.F. Lodish. 1997. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. 94: 10669-10674.
24. Luo, K. and H.F. Lodish. 1996. Signalling by chimeric erythropoietin-TGF-β receptors: Homodimerization of the cytoplasmic domain of the type I TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. EMBO J. 15: 4485-4496.
25. Macias-Silva, M., S. Abdollah, P.A. Hoodless, R. Pirone, L. Attisano, and J.L. Wrana. 1996. MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224.
26. Massague, J., A. Hata, and F. Liu. 1997. TGF-β signalling through the Smad pathway. Trends Cell Biol. 7: 187-192.
27. Nakao, A., T. Imamura, S. Souchelnystkyi, M. Kawabata, A. Ishisaki, E. Oeda, K. Tamaki, J. Hanai, C.-H. Heldin, K. Miyazono, P. ten Dijke et al. 1997. TGF-β receptor-mediated signalling through Smad2, Smad3, and Smad4. EMBO J. 16: 5353-5362.
28. Onishi, M., S. Kinoshita, Y. Morikawa, A. Shibuya, J. Phillips, L.L. Lanier, D.M. Gorman, G.P. Nolan, A. Miyajima, and T. Kitamura. 1996. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24: 324-329.
29. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper free retroviruses by transient transfection. Proc. Natl. Acad. Sci. 90: 8392-8396.
30. Rasheed, S. 1995. Retroviruses and oncogenes. In The retroviride (ed. J.A. Levy), pp. 293-306. Plenum Press. New York, NY.
31. Riccio, A., P.V. Pedone, L.R. Lund, T. Olesen, H.S. Olsen, and P.A. Andreasen. 1992. Transforming growth factor β1-responsive element: Closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene. Mol. Cell. Biol. 12: 1846-1855.
32. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Souchenlnytskyi, S., K. Tamaki, U. Engstrom, C. Wernstedt, P. ten Dijke, and C.-H. Heldin. 1997. Phosphorylation of Ser465 and Ser467 in the C terminus of Smads mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J. Biol.Chem. 272: 28107-28115.
34. Vindevoghel, L., A. Kon, R. Lechleider, J. Uitto, A. Roberts, and A. Mauviel. 1998. Smad-dependent transcriptional activation of human type VII collagen gene (COLL7A1) promoter by transforming growth factor-β. J. Biol. Chem. 273: 13053-13057.
35. Wang, X., M.R. Briggs, X. Hua, C. Yokoyama, J.L. Goldstein, and M.S. Brown. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter II. J. Biol. Chem. 286: 14497-14504.
36. Weis-Garcia, F. and J. Massague. 1996. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15: 276-289.
37. Westerhausen Jr., D.R., W.E. Hopkins, and J.J. Billadello. 1991. Multiple transforming growth factor-β-inducible elements regulate expression of the plasmigogen activator inhibitor type-1 gene in Hep G2 cells. J. Biol. Chem. 266: 1092-1100.
38. Wieser, R., J. Wrana, and J. Massague. 1995. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14: 2199-2208.
39. Wrana, J.L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X.-F. Wang, and J. Massagué. 1992. TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014.
40. Wrana, J.L., L. Attisano, R. Wieser, V. Francesc, and J. Massague. 1994. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347.
41. Yingling, J., M. Datto, C. Wong, J. Frederick, N. Liberati, and X. Wang. 1997. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol. 17: 7019-7028.
42. Zawel, L., J. Dai, P. Buckhaults, S. Zhou, K. Kinzler, B. Vogelstein, and S. Kern. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1: 611-617.
43. Zhang, Y., X.-H. Feng, R.-Y. Wu, and R. Derynck. 1996. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383: 168-172.
44. Zhao, G.-Q., Q. Zhao, X. Zhou, M.-G. Mattei, and B. DE Combrugghe. 1993. TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation. Mol. Cell. Biol. 13: 4505-4512.